Physicians' Perception About Patient Pain in Flexible Cystoscopy With Local Anesthesia

April 24, 2025 updated by: Tarik Emre Sener, Marmara University
Cystoscopy with local anesthesia is commonly performed for the follow-up of bladder cancer, evaluation of hematuria, assessment of urethral strictures, and examination of the lower urinary tract. While some patients tolerate the procedure comfortably, others may exhibit heightened sensitivity and difficulty tolerating it. In certain cases, even when the procedure is completed, the level of pain experienced and the resistance demonstrated by the patient may render cystoscopy a challenging experience for both the patient and the physician. The physician's perception of the patient's pain may differ from the pain reported by the patient. Currently, there is no available data in the literature regarding the relationship between pre-procedural anxiety and depression levels and the pain experienced during cystoscopy, nor regarding the physician's perception of that pain. The primary objective of the study is to compare the patient-reported pain score with the physician's perception of the pain experienced by the patient. A secondary objective is to evaluate the pre-procedure anxiety and depression scores, along with intra-procedural pain scores, in patients undergoing flexible cystoscopy under local anesthesia.

Study Overview

Status

Enrolling by invitation

Detailed Description

Cystoscopy is one of the most frequently performed procedures in the field of urology. Its widespread application, the impracticality of administering general anesthesia to all patients, and advancements in medical technology have led to the development of devices that enable cystoscopy to be performed with local or intraurethral anesthesia. As a result, cystoscopy under local anesthesia is commonly utilized for the follow-up of bladder cancer, evaluation of hematuria, assessment of urethral strictures, and examination of the lower urinary tract. Both rigid and flexible cystoscopes can be used for this purpose, with flexible instruments generally offering greater comfort for procedures involving local anesthesia.

In patients undergoing cystoscopy with local anesthesia, the standard approach includes the intraurethral administration of a local anesthetic or lubricant prior to the procedure to enhance patient comfort. While some patients tolerate the procedure well, others may exhibit heightened sensitivity and limited tolerance. Even in cases where the procedure is completed, the pain experienced and the resistance demonstrated by the patient may pose challenges for both the patient and the physician. Occasionally, a mismatch is observed between the patient's reported pain and the resistance displayed. The physician's perception of the patient's pain may also differ from the pain reported by the patient.

Previous studies have explored factors that can influence and reduce the perception of pain during cystoscopy performed under local anesthesia. However, data are lacking regarding the relationship between patients' pre-procedural anxiety and depression levels and the pain experienced during the procedure, as well as the physician's perception of that pain. The primary aim of the study is to compare the pain score reported by the patient with the pain level perceived by the physician. A secondary objective is to evaluate patients' pre-procedure anxiety and depression scores, along with their pain scores during the procedure, in the context of flexible cystoscopy performed under local anesthesia.

The study will include male patients aged 18 years and older who are undergoing cystoscopy due to urological complaints. Exclusion criteria include patients with known urethral strictures or those diagnosed with strictures during cystoscopy, individuals with allergies to the local anesthetic used, and patients with cardiopulmonary conditions that preclude the procedure.

Participants will be asked to complete the Hospital Anxiety and Depression Scale (HADS) for the assessment of general anxiety and depression, as well as the Visual Analog Scale (VAS) for pain and anxiety, at the time of admission. All patients will receive standard intraurethral local anesthesia 15 minutes prior to the procedure. Following cystoscopy, participants will complete the VAS for anxiety and pain again, 15 minutes after the procedure, to evaluate their intra-procedural experience. In addition, the physician performing the procedure will complete the VAS for anxiety and pain based on their perception of the patient's experience.

Patients will be randomized into four groups based on the experience level of the physician performing the procedure: a physician with more than five years of experience, a physician with less than five years of experience, a second-year resident under supervision, and a fourth-year resident. A total of 30 patients will be included in each group. The physician will remain blinded to the forms completed by the patient before and after the procedure and will independently assess the patient's condition.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34662
        • Marmara University, School of Medicie, Department of Urology, Istanbul, Türkiye

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Minimum Age: 18 Years Maximum Age: Not Applicable Sex: Male Gender Based: Yes Male patients over 18 years of age who need cystoscopy due to urologic complaints will be included in the study.

Accepts Healthy Volunteers: No

Inclusion Criteria:

Male patients

Over 18 years of age

Patients for whom diagnostic cystoscopy is indicated for a urologic reason

Exclusion Criteria:

Female patients

Patients younger than 18 years of age

Patients with known urethral stricture

Patients with urethral stricture detected during cystoscopy

Patients who cannot tolerate flexible cystoscopy with local anesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Assistant Urology Doctor (2 years)
Intervention: Diagnostic Flexible Cystoscopy Other Names: Flexible Cystoscopy, Cystoscopy Arm Description: The procedure will be performed by an Assistant Urology Doctor with 2 years of experience. The goal is to evaluate the patient's pain perception during diagnostic flexible cystoscopy.
Diagnostic Flexible Cystoscopy
Other Names:
  • Flexible Cystoscopy
Diagnostic Flexible Cystoscopy
Other Names:
  • Cystoscopy
Experimental: Assistant Urology Doctor (4 years)
Intervention: Diagnostic Flexible Cystoscopy Other Names: Flexible Cystoscopy, Cystoscopy Arm Description: The procedure will be performed by an Assistant Urology Doctor with 4 years of experience. The goal is to evaluate the patient's pain perception during diagnostic flexible cystoscopy.
Diagnostic Flexible Cystoscopy
Other Names:
  • Flexible Cystoscopy
Diagnostic Flexible Cystoscopy
Other Names:
  • Cystoscopy
Experimental: Specialist Urology Physician (<5 years experience)
Experimental: Specialist Urology Physician (<5 years experience) Intervention: Diagnostic Flexible Cystoscopy Other Names: Flexible Cystoscopy, Cystoscopy Arm Description: The procedure will be performed by a Specialist Urology Physician with less than 5 years of experience. The goal is to evaluate the patient's pain perception during diagnostic flexible cystoscopy.
Diagnostic Flexible Cystoscopy
Other Names:
  • Flexible Cystoscopy
Diagnostic Flexible Cystoscopy
Other Names:
  • Cystoscopy
Experimental: Specialist Urology Physician (>5 years experience)
Experimental: Specialist Urology Physician (>5 years experience) Intervention: Diagnostic Flexible Cystoscopy Other Names: Flexible Cystoscopy, Cystoscopy Arm Description: The procedure will be performed by a Specialist Urology Physician with more than 5 years of experience. The goal is to evaluate the patient's pain perception during diagnostic flexible cystoscopy.
Diagnostic Flexible Cystoscopy
Other Names:
  • Flexible Cystoscopy
Diagnostic Flexible Cystoscopy
Other Names:
  • Cystoscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physicians' Perception about Patient Pain in Flexible Cystoscopy with Local Anesthesia
Time Frame: Immediately after the procedure, upon completion of the diagnostic flexible cystoscopy (15 minutes post-procedure).

The study will examine the differences in the perception of pain scores in patients according to the years of experience of physicians.

Scale Used: Visual Analog Scale (VAS) for Pain Minimum Value: 0 (No pain) Maximum Value: 10 (Worst possible pain) Interpretation: Higher scores indicate worse pain perception.

Immediately after the procedure, upon completion of the diagnostic flexible cystoscopy (15 minutes post-procedure).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association between patients' pre-procedure HAD score and pain
Time Frame: Pre-procedure (baseline), immediately after the procedure (15 minutes post-procedure).
Depression and anxiety levels in the pre-procedure HAD scores and VAS pain scores during the procedure will be compared.
Pre-procedure (baseline), immediately after the procedure (15 minutes post-procedure).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Haydar Kamil Cam, Professor Doctor, Marmara University, School of Medicie, Department of Urology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2025

Primary Completion (Estimated)

August 15, 2025

Study Completion (Estimated)

September 15, 2025

Study Registration Dates

First Submitted

March 8, 2025

First Submitted That Met QC Criteria

April 23, 2025

First Posted (Actual)

April 25, 2025

Study Record Updates

Last Update Posted (Actual)

April 27, 2025

Last Update Submitted That Met QC Criteria

April 24, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • MAR.UAD.0021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Demographic data, Hospital Anxiety and Depression Scale (HADS) scores, and Visual Analog Scale (VAS) pain scores collected during the study will be shared with researchers upon request. The data will be anonymized to ensure participant privacy and confidentiality. The sharing will occur in compliance with ethical guidelines and institutional policies.

IPD Sharing Time Frame

The IPD and supporting information will be available starting from the study completion date (September 15, 2025) and will be accessible for a period of 5 years.

IPD Sharing Access Criteria

The IPD and supporting materials will be available to qualified researchers upon request. Researchers will have access to anonymized demographic data, Hospital Anxiety and Depression Scale (HADS) scores, Visual Analog Scale (VAS) pain scores, study protocol, statistical analysis plan, informed consent forms, and the final clinical study report. Access will be granted through a secure, password-protected data-sharing platform hosted by Marmara University, with adherence to ethical guidelines and confidentiality protocols. Requests can be made by contacting the study's central contact person, Dr. Gunal Ozgur (email: gunalozgur91@hotmail.com).

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Diagnostic procedures

Subscribe